Price target
34.29RUSD+10.04+41.38%
The 7 analysts offering 1 year price forecasts for Catalyst Pharmaceuticals, Inc. have a max estimate of 40.00 and a min estimate of 32.00.
Analyst rating
Based on 7 analysts giving stock ratings to Catalyst Pharmaceuticals, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
6
Buy
1
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.50
−0.25
0.00
0.25
0.50
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.33
−0.29
0.31
0.19
0.33
0.35
0.44
—
—
—
—
Estimate
0.25
−0.30
0.27
0.20
0.23
0.30
0.34
0.34
0.36
0.36
0.34
Surprise
+29.92%
+3.33%
+16.98%
−4.20%
+44.74%
+15.13%
+29.96%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
40.00 M
80.00 M
120.00 M
160.00 M
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
99.48 M
102.62 M
109.10 M
98.44 M
122.65 M
126.42 M
141.81 M
—
—
—
—
Estimate
91.71 M
100.37 M
105.93 M
98.78 M
111.77 M
123.41 M
134.17 M
130.90 M
139.56 M
139.16 M
144.88 M
Surprise
+8.46%
+2.24%
+3.00%
−0.34%
+9.74%
+2.44%
+5.69%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CPRX EPS for the last quarter is 0.44 USD despite the estimation of 0.34 USD. In the next quarter EPS is expected to reach 0.34 USD. Track more of Catalyst Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Catalyst Pharmaceuticals, Inc. revenue is expected to reach 130.90 M USD. Check out Catalyst Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, CPRX price target is 34.29 USD with a max estimate of 40.00 USD and a min estimate of 32.00 USD. Check if this forecast comes true in a year, meanwhile watch Catalyst Pharmaceuticals, Inc. stock price chart and keep track of the current situation with CPRX news and stock market news.
We've gathered opinions of 7 analysts rating CPRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.